Clinical Trial Update: A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection [Phase 2]

View source ↗

Summary

This Phase 2 trial compares tobevibart plus elebsiran against bulevirtide in adults with chronic hepatitis D virus infection; the study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Bulevirtide (bulevirtide)
• Elebsiran
• Tobevibart

Snippet

Sponsor: Vir Biotechnology, Inc. | Conditions: Viral Hepatitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING